Cardiology monitoring substudy in the PERSEPHONE trial: 6 versus 12 months of trastuzumab

Category Primary study
JournalJournal of Clinical Oncology
Year 2014
This article has no abstract
Epistemonikos ID: 8e3cfde4760f13bb4eb12b7a34f74681c1c069c1
First added on: Feb 06, 2025